ORBIMED ADVISORS LLC - 30 Jun 2025 SCHEDULE 13G Report for CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: OrbiMed Advisors LLC
Security: CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol: CTMX
Shares outstanding: 156,694,444 shares
Disclosed Ownership: 8,461,500 shares
Ownership: 5.4%
Form type: SCHEDULE 13G
Filing time: 14 Aug 2025, 18:07:11 UTC
Date of event: 30 Jun 2025
Next filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
OrbiMed Advisors LLC	5.4%	8,461,500	0	8,461,500	/s/ Carl L. Gordon	Carl L. Gordon / Member of OrbiMed Advisors LLC